John powers stanford management biography

INVESTMENT RESULTS IMPROVE SHARPLY

Stanford's investments generated a 14.4 percent return for the 12 months ended June 30, and the University's endowment was valued at approximately $13.8 billion as of August 31, the last day of the fiscal year.

Media coverage of the results—which confirmed a sharp turnaround from the recession-driven decline of 25.9 percent that occurred in 2008-09—noted the lesser returns at the two wealthiest U.S. universities, Harvard and Yale. Harvard, with an endowment of $27.4 billion, reported an 11 percent return; Yale, at $16.7 billion, an 8.9 percent return.

Stanford's gains came from its merged pool of investments, which includes most of the University's endowment and expendable funds, as well as capital reserves from its hospital and clinics and Lucile Packard Children's Hospital. The endowment's value rose 9.6 percent over the previous year; it is calculated from investment results plus gifts and other funds transferred into the endowment, offset by the annual payout made for University operations. The budgeted payout for fiscal 2011 is $758 million.

"Our investment managers took advantage of strong equity and credit markets through the first three quarters of the fiscal year," John Powers, chief executive of Stanford Management Company, said in a statement. "Efforts to diversify and mitigate risk" were helpful during a "challenging June quarter."

BUSTAMANTE GIVEN 'GENIUS GRANT'

Bustamante's research exam

John Powers, the chief executive officer of Stanford Management Co. who pushed the university”s endowment from $12 billion to $21.4 billion over the past eight years, will leave the campus next year, Stanford News Service reported Tuesday.

Powers did not specify where he is going, saying, “I have decided that it is time to take my enthusiasm for business building and find a new challenge.”

The 1983 Stanford business school alum announced he will leave his post in 2015 but will remain CEO until a replacement can be appointed.

The university has launched a national search for his successor.

In the five years since the recession, Powers managed a portfolio that compounded 13.1 percent annually, according to Stanford News Service.

Last year, it showed a 17 percent return, compared with Harvard”s 15.4 percent.

It paid out $985 million in 2014 for the university to use in running its operations.

Contact Lisa M. Krieger at 650-492-4098.

Originally Published:

Robert F. Wallace, chief executive officer and chief investment officer of Alta Advisers, a London-based private investment firm, has been named president and chief executive officer of the Stanford Management Company (SMC).

Wallace will succeed John Powers, who announced last fall that he would be leaving his post after nine years at the helm. Wallace will begin transitioning to his new duties overseeing SMC immediately, assuming the role full time later this year.

At Alta Advisers, Wallace oversees a global, multi-asset-class investment program. Prior to joining Alta in 2005, Wallace worked at the Yale Investments Office, which manages the Yale University Endowment. He serves on the investment committee of Cambridge University.

“Rob Wallace brings expertise in global financial management, as well as an understanding of the importance of endowment management to support higher education,” said Stanford President John Hennessy. “We look forward to having him join Stanford, and to his leadership of the organization that provides crucial support to the university’s teaching and research mission.”

Wallace said he is delighted to join SMC and the Stanford community.

“The Stanford endowment is a critical resource for the university’s present and future students and scholars,” Wallace said. “I am very fortunate to have the opportunity to lead Stanford Management Company and to contribute to such an important mission and institution.”

The Stanford Management Company oversees more than $25 billion of endowment and trust assets, temporarily invested expendable funds, and commercial real estate investments. The income generated from SMC’s work supports Stanford’s research and teaching, including student and faculty support, capital improvements and infrastructure, and operational funds.

The Stanford Management Company was established in 199

Founder and CEO of Aerogen - Leadership Excellence in Medical Devices

Profile

A serial entrepreneur in a technology and innovation focused career spanning over 30 years, John has held executive-level positions in R&D, Operations, Sales, and General Management in both the SME and MNC environment. During this period he has been a founder or co-founder of several ÔBlue Ocean’ technology start-ups, the last three of these in the life-science sector.

John has led the company from a start-up in 1997 through a US merger, NASDAQ IPO, trade sale and return to a privately held company by MBO in 2008. Today, Aerogen is recognised as a pioneer and the global leader in ICU ventilator/hospital-based aerosol drug delivery. Its award-winning products are employed in over 75 countries throughout the world, helping to provide life critical interventions from the emergency department through to the NICU. Aerogen’s proprietary technology permits proteins, peptides, suspensions and solutions to be nebulized, paving the way for targeted drug delivery to the lung.

Under John’s Leadership Aerogen has achieved circa 30% CAGR since 2008 and in recognition of its export success, Aerogen was awarded the prestigious European Business Award Ruban d’Honneur in 2011 and again in 2016, when John was also named the European Entrepreneur of the Year. As a leader within the Irish life-science sector, Aerogen was named both The Irish Med-Tech Company of the Year and The Irish Exporter of the Year. The Company has received the highest award granted by the US respiratory community, the American Association of Respiratory Care, the Zenith Award, for Ôproviding products and services that enable respiratory care physicians and therapists to achieve clinical excellence’.

A Chartered Engineer, John is recognized as a technology innovator and is credited with over a dozen commercialized international patents in products ranging from robotics to life-suppor